StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for XRN yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $34.40 | $33.53 | -2.53% | 0.1M |
| 05-18 | $33.28 | $34.11 | +2.49% | 0.2M |
| 05-19 | $33.77 | $34.34 | +1.69% | 0.2M |
| 05-20 | $34.28 | $36.25 | +5.75% | 0.3M |
| 05-21 | $36.15 | $37.34 | +3.29% | 0.2M |
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure. Its portfolio includes Spectrum-Dumfries, Slippery Rock MOB, Gainesville Eye Center, Aurora Sports Health, and many Others. Geographically, the company has it's concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $43.00K | $526.00K | $306.00K | $112.00K |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $1.65M | $-6.88M | $-736.00K | $4.32M |
EPS (Diluted) | $-0.06 | $-0.91 | $-0.35 | $0.02 |
Total Assets | $1.24B | $1.24B | $1.27B | $1.30B |
Total Liabilities | $717.37M | $712.40M | $767.41M | $771.94M |
Cash & Equivalents | $8.18M | $9.08M | $7.12M | $6.58M |
Free Cash Flow OCF − CapEx | $11.21M | Not available | Not available | Not available |
Shares Outstanding | 13.23M | 13.23M | 13.41M | 66.88M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.